PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
Langue : Anglais
The PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013 is the
leading resource for statistics, trends, and proprietary market
intelligence and analysis on the biopharmaceutical industry. Supported by
thousands of graphs, illustrations, and analysis, the Sourcebook provides
the latest market intelligence on every aspect of biopharmaceutical
development – from product discovery, to R&D performance and productivity,
to time-to-market trends. With key analysis and contributions from leading
consultancies and experts, the Sourcebook provides real-world data and
analysis, including: A record number of all-new metrics on drug
development costs and complexity New proprietary analyses on US clinical
trial starts, segmented by therapeutic category, as well as overall active
clinical trials Emerging data on worldwide and company-specific R&D
pipelines, strategies, and product launch trends New analyses on emerging
trends in pharma and biotech licensing deals and other partnerships
critical to industry's efforts Drug approval statistics compiled from FDA,
EMEA, and other regulatory agencies New global R&D spending trends and
other international R&D data from key markets. International statistics
on drug development output and much more! Plus, NEW in the 2012/2013
edition: An all-new 2012 analysis on the current share of clinical trial
spending by region for 2011. All-new studies on the emerging clinical
trial markets in India, China, Korea, Canada, and dozens of other key
markets and regions. All-new analyses and actual/projected metrics on the
biosimilars market. A series of new "dashboards" on costs by phase of
development, R&D attrition rates, product development times, and other
areas Forecasting models on biopharma sales, R&D spending, the
pharma/biotech markets, and other meaningful industry metrics. The PAREXEL
Biopharmaceutical R&D Statistical Sourcebook 2012/2013 is a must-have
resource for the drug development industry. It is an invaluable resource
for executives and managers working in the pharma and biotech industries.
The Sourcebook puts real-world data sets at your fingertips for
presentations, reports, business development efforts, strategic meetings,
and critical decision-making analyses.
Ouvrage de 368 p.
Thèmes de PAREXEL Biopharmaceutical R&D Statistical Sourcebook... :
© 2024 LAVOISIER S.A.S.